Conversely, basal and null/double negative molecular subtypes shared a higher frequency of MIBC enriched in variant histology, with high PD-L1 expression (likely to respond to ICI immunotherapy) and worse bladder cancer-related mortality. This evidence concerns the gene CD274 and urinary bladder carcinoma.